HealthMore in Health→
Researchers identify Sirt1 as target in aggressive prostate cancer
Key Takeaways
- A Columbia-led study identified Sirt1 as a driver of neuroendocrine prostate cancer.
- Blocking Sirt1 prevented NEPC tumor growth in mice.
- The findings could inform future clinical work on treatment-resistant prostate cancer.
DE
DT Editorial Team··via medicalxpress.com